In-Hospital and 30-Day Stroke Mortality

Methods
Case Identification and Data Abstraction
Details of the design and conduct of the GWTG-Stroke program have been described elsewhere. 6, 7 Briefly, we included data from a starting population of over 1.6 million acute ischemic stroke patients admitted to over 1900 GWTG-Stroke hospitals who participated in the program during the 10-year period between April 2003 and December 2013. Trained hospital personnel were instructed to ascertain consecutive acute stroke admissions by either prospective clinical identification, retrospective identification using International Classification of Diseases Ninth Revision discharge codes (433.x, 434.x, 436), or a combination. The eligibility of each acute stroke admission was confirmed at chart review prior to abstraction.
Data on hospital-level characteristics were obtained from the GWTG program or the American Hospital Association database. 8 All participating hospitals received human research approval to enroll stroke patients in the GWTG program. All patient data were deidentified before submission. Outcome Sciences (Cambridge, MA) serves as the data collection and coordination center for GWTG, and the Duke Clinical Research Institute serves as the data analysis center.
Patient Population
The starting population was 1 648 032 acute ischemic strokes that were admitted to 1907 hospitals that participated in the GWTGStroke program between April 2003 and December 2013. These data were linked to fee-for-service Medicare (Centers for Medicare and Medicaid Services) using previously developed methods that matched individual stroke admissions on the basis of hospital, admission, and discharge dates, date of birth, and sex. 9 After linking, we excluded 542 376 admissions (32.9%) because they were <65 years of age, 450 407 admissions (27.3%) because they could not be linked to the fee-for-service claims data, and 34 391 admissions (2.1%) because they were not fee-for-service eligible. Of the remaining 620 858 admissions, we excluded 68 388 (11.0%) because they were transferred in from another hospital, 7254 (1.2%) because they were transferred out to another hospital, and 5885 (0.9%) because they left AMA or disposition was not documented. We excluded 310 hospitals that provided data on <25 total admissions during the 10-year period (which represented 3125 admissions [0.5%]). This left a final database of 536 230 acute ischemic stroke admissions from 1494 hospitals. Comparison between these cases in this final database and the cases that could not be linked to fee-for-serve claims data (n=327 578) are shown in Table IA in the Data Supplement. Cases that were not linked to claims data were slightly younger than those that were linked (78.4 versus 80.1 years) and more likely to be from racial minorities (ie, black 14.1% versus 10.3%, Hispanic 7.6% versus 3.9%, Asian 3.8% versus 1.9%). Other differences in medical history, comorbidities, and clinical features were minimal.
GWTG-Stroke Risk Score Models
Although Centers for Medicare and Medicaid Services has developed claims based statistical models to risk-standardize 30-day mortality outcomes for several conditions, including pneumonia and cardiac disease, 10-12 these models have not been applied to in-hospital mortality. Moreover, the approach to developing risk-standardized outcomes for acute stroke remains controversial because of the inability of claims data to satisfactorily account for stroke severity 13, 14 We, therefore, relied on 2 previously generated risk scores that were developed by the GWTG-Stroke program to provide prognostic estimates for ischemic stroke patients based on in-hospital mortality. 15 Further details of the application of these models to our data are provided in the Data Supplement; 2 versions of the multivariable risk score were used depending on whether National Institutes of Health Stroke Scale (NIHSS) data were available. Both models had good discrimination; the C statistics for the models with and without NIHSS data were 0.85 and 0.72, respectively, and both demonstrated excellent calibration.
Main Analyses
The main analyses were based on the hospital-specific in-hospital and 30-day risk-standardized mortality rates (RSMRs) that were generated using the 2 previously developed GWTG risk score models. 15 Because of the impact of combining discharge to hospice with inhospital mortality data, we repeated all of the analyses after creating a composite outcome measure of in-hospital mortality or discharge to hospice. These analyses were done on the final study population (536 230 admissions).
Statistical Analysis
Frequencies, means and median descriptive statistics were generated to describe the patient-level and hospital-level characteristics of the primary study population (536 230 admissions). Pearson χ 2 tests for nominal data and Wilcoxon rank-sum tests for ordinal and continuous data were used to test for statistical associations. Patient-level and hospital-level observed mortality rates were generated for both the in-hospital and 30-day time points. χ 2 tests for linear trend were used to assess trends in mortality and LOS across time (ie, 2003-2013) .
We followed established statistical methods to generate RSMRs using generalized linear mixed models that included hospital-specific random effects to account for between-hospital differences in baseline mortality. 10, 14, 16 Further details on the development of the RSMRs are described in the Data Supplement.
Identification of Hospital Outliers
Designation of an individual hospital as being an outlier because of either high or low mortality was determined using 2 approaches. The first identified individual hospitals whose risk-adjusted mortality was statistically significantly different from the average hospital.
14, 16 The second approach 13 ranked all hospitals based on their RSMR and then categorized them into 3 groups: the highest quintile (20%) of hospitals with high mortality, the bottom quintile (20%) of hospitals with
WHAT IS KNOWN
• Current methods used to identify outlier hospitals with high or low mortality typically rely on 30-day mortality data, but obtaining these data is complicated because it requires tracking individual patients post-discharge or linking to administrative or vital records data.
• Hospitals do have access to in-hospital mortality data, which might serve as a satisfactory proxy for 30-day mortality. However, previous studies found only modest correlation between in-hospital mortality and 30-day mortality.
WHAT THE ARTICLE ADDS
• We used Get With The Guidelines (GWTG)-Stroke data linked to fee-for-service Medicare data to compare hospital outlier status based on risk-standardized ischemic stroke mortality data using 2 different time points-in-hospital and 30-day.
• We found that the correlation between risk-standardized in-hospital mortality and 30-day mortality was only modest (r= 0.53), but if in-hospital mortality was combined with data on discharge to hospice, this new outcome measure had a much stronger correlation with 30-day mortality (r= 0.85).
• For ischemic stroke patients, the composite outcome of in-hospital mortality or discharge to hospice could serve as an adequate proxy for 30-day mortality data.
low mortality, and the middle 60% of hospital which were labeled as having typical mortality. 1, 13 Further details on the identification of outlier hospitals based on the RSMRs are described in the Data Supplement.
To compare the agreement between hospital RSMRs generated from in-hospital and 30-day mortality data, we first generated rank correlation statistics. We then compared the agreement in hospital outlier designation between the 2 time points-in-hospital and 30-days-by creating cross-classification tables and calculating overall agreement, as well as chance-corrected agreement (using weighted κ). We did this for both approaches used to identify outliers (statistical outlier and 3-group relative ranking).
Additional Analyses
In secondary analyses conducted at the hospital level, we explored the impact of 4 factors that were anticipated to influence the relative balance between in-hospital and 30-day mortality rates. This included (1) the mean hospital LOS (days), (2) the mean hospital transfer out rate (ie, proportion of stroke patients transferred to an acute care hospital), (3) the mean hospital rate of comfort measures only (ie, proportion of stroke patients who receive limited care during the in-hospital stay), and (4) the mean hospital rate of discharge to hospice. Following previously developed methods, 1 we used weighted linear regression models to quantify the association between each factor (as single explanatory variables) on both in-hospital and 30-day RSMRs, using the total number of ischemic stroke patients treated at each hospital as weights.
Finally, we conducted a sensitivity analysis where we repeated all of the analyses using the GWTG-Stroke risk score model that incorporated NIHSS; these analyses were restricted to 306 423 admissions from 1254 hospitals with documented NIHSS data.
Results
The characteristics of the final study population of 536 230 acute ischemic stroke patients are shown in Table 1 . The mean age was 80 years, 59% were female, 19% were nonwhite, and 58% arrived by ambulance. The NIHSS was recorded in 58% of cases and had a mean of 7.7. About half of the patients were treated at a teaching hospital or a primary stroke center. The characteristics of the 1494 GWTG-Stroke hospitals included in the final study population are shown in Table IVA in the Data Supplement; slightly less than half of the sites were teaching hospitals and 35% were primary stroke centers.
The overall in-hospital and 30-day mortality rates calculated at the patient level were 5.7% and 14.5%, respectively. Table 2 provides descriptive summaries of the observed mortality and RSMRs calculated at the hospital-level for both in-hospital and 30-day outcomes, as well as the net difference between the 2. The frequency distributions of these 3 hospitallevel measures are shown in Figure 1 . The variation in RSMRs was, as expected, smaller than that of the observed mortality rates (as indicated by the smaller SDs, interquartile range, and ranges) The correlation between the in-hospital and 30-day RSMR values for 1494 GWTG-Stroke hospitals is shown in Figure 2A ; the Pearson correlation coefficient was 0.53 (P<0.001). Figure 2B shows the correlation based on the hospital rankings from the RSMR values; the Pearson correlation coefficient was only 0.45 (P<0.001). The agreement in designation of outlier hospitals between in-hospital and 30-day RSMRs using the statistical definition of outlier status is shown in Table 3 . Twenty percent of hospitals were designated as outlier hospitals based on in-hospital RSMRs, while fewer hospitals (15%) were designated as outliers based on 30-day RSMRs. While the overall agreement was 78%, the chancecorrected agreement was only fair (weighted κ=0.29). Of the 189 hospitals who were designated as having high mortality based on in-hospital mortality, only 61 (32%) remained high outliers according to the 30-day mortality data. Similarly, of the 109 hospitals who were designated as having low mortality based on in-hospital data, only 28 (26%) remained low outliers according to the 30-day data. The agreement in hospital outlier designation between in-hospital and 30-day RSMRs using the 3-group relative ranking method is shown in Table VA in the Data Supplement; the overall agreement was now only 58%, and chance-corrected agreement remained only fair (weighted κ=0.34). There were again large misclassification errors when in-hospital mortality was used to identify mortality outliers.
The results of the weighted linear regression analyses of the 4 hospital-level factors on in-hospital and 30-day RSMRs are shown in Table VIA in the Data Supplement. Of the 4 factors examined, discharge to hospice had the strongest relationship with mortality; a 1% increase in the mean hospice discharge rate was associated with a significant decrease in inhospital mortality (−0.27%; P<0.001) but an almost equal and concomitant increase in 30-day mortality (0.25%; P<0.001). Because of the strong influence of discharge to hospice on both in-hospital and 30-day mortality, we repeated our main analyses after creating a new combined outcome of in-hospital mortality or discharge to hospice. This composite outcome was observed in 11.6% of subjects. As illustrated in Figure  IIA in the Data Supplement, over the 10-year duration of the study, the proportion of patients discharged to hospice more than doubled from 3.1% in 2003 to 6.7% in 2013 (CochranArmitage trend test, P<0.0001), resulting in an increase in the combined outcome of in-hospital mortality or hospice discharge from 9.4% in 2003 to 11.8% in 2013 (CochranArmitage trend test, P<0.0001). Overall, 84.5% of patients discharged to hospice died within 30 days; this proportion varied slightly between years, but there was no overall significant trend (P=0.07). The coefficients for the risk score model based on the combined outcome are shown in Table VIIA Descriptive summaries of the observed and risk-standardized rates (calculated at the hospital-level) for the combined outcome of in-hospital mortality or hospice discharge are shown in Table 4 , and the frequency distributions of the hospitallevel measures (including the combined outcome) are shown in Figure VIA in the Data Supplement. The mean hospital risk-standardized rate for the combined outcome of in-hospital mortality or hospice discharge was 11.8%, and the mean difference between it and the 30-day RSMR was only 2.8%. The net result was that the correlation between the risk-standardized rate of the combined outcome and 30-day RSMRs increased substantially to 0.83 ( Figure 2C ). The higher correlation between the 2 measures resulted in substantially better agreement in identifying outlier hospitals. Based on a statistical definition of outlier status, overall agreement between the 2 measures increased to 88% with a weighted κ of 0.60 indicating good agreement beyond chance (Table 5 ). Of the 162 hospitals who were designated as being high outliers based on the combined outcome, now more than half (n=88) remained high outliers according to the 30-day RSMR data. Similarly, of the 128 hospitals who were designated as being low outliers based on the combined outcome, more than half (n=70) remained low outliers according to the 30-day data. Results based on the 3-group rankings approach (Table VIIIA in the Data Supplement) were also better; the overall agreement and kappa increased to 74% and 0.61%, respectively. Finally, the results of the sensitivity analysis that were based on the risk-adjustment models that included stroke severity data (n=306 423 admissions from 1254 hospitals) were similar to those presented in the main analyses (see Data Supplement).
Discussion
Using data from almost 1500 US hospitals that participated in a large stroke quality improvement program, we sought to determine whether risk-standardized in-hospital mortality for ischemic stroke could serve as an adequate proxy for riskstandardized 30-day mortality data-the gold standard for identifying outlier hospitals. We found that in-hospital mortality was not a satisfactory proxy for 30-day mortality; the correlation between in-hospital risk-standardized mortality and 30-day risk-standardized mortality was only modest (r= 0.53), and the level of agreement between the 2 measures to identify outlier hospitals was only fair (κ=0.29). However, after further analyses, we found that when data on discharge to hospice was combined with in-hospital mortality data, this expanded outcome measure had a much stronger correlation with 30-day risk-standardized mortality (r= 0.83), and the agreement between the 2 measures when identifying outlier hospitals was greatly improved (κ=0.60). The value of combining discharge to hospice data with in-hospital mortality data is most clearly demonstrated when the combined measure is used to identify *RSMRs based on model without NIHSS data. In-Hospital and 30-Day Stroke Mortality outlier hospitals. Among 110 hospitals that were identified as having higher than expected risk-standardized 30-day mortality, only 55% (n= 61) were identified as high outliers based on in-hospital mortality data; however, this increased to 80% (n=88) when the combined outcome of in-hospital death or discharge to hospice was used. Similarly, of the 102 hospitals that had lower than expected risk-standardized 30-day mortality, only 27% (n=28) were confirmed as low outliers based on in-hospital mortality, but this increased to 68% (n=70) for the combined outcome. These results indicate that when used to identify outlier hospitals, the combined outcome of in-hospital mortality and discharge to hospice represents a substantial improvement over in-hospital mortality alone. The reason for the high correlation (r= 0.83) between the combined outcome of in-hospital mortality or discharge to hospice and 30-day mortality is in large part because of the fact that 85% of patients discharged to hospice died within 30 days of the index hospital admission. Our data indicate that 60% of the deaths that occurred within 30 days of admission occur after the patient has been discharged from the acute hospital setting, and of these deaths, 57% occurred in patients who were discharged directly to hospice. Previous authors have made the recommendation that early postdischarge mortality be included in the calculation of hospital-based mortality measures, 2 and our data indicate that identifying patients discharged to hospice is an easy way of capturing a substantial proportion of the deaths that occur in the period between hospital discharge and 30 days post-admission. The fact that 30-day mortality data are difficult to generate for most hospitals dictates that alternative approaches be explored. We think that using the combined outcome of in-hospital mortality and discharge to hospice is a rational and practical choice for hospitals interested in monitoring their own performance.
The findings of this study are also important because they illustrate how the in-hospital mortality rate can be affected by hospital discharge practices-a phenomenon referred to as the discharge bias effect.
2,4 Specifically, we found a strong positive relationship between hospital LOS and in-hospital mortality-the longer the average LOS, the higher the average in-hospital mortality-which confirms the results of previous studies.
1,2 We also found a significant positive association between the use of comfort measure care and in-hospital mortality, as well as an inverse association between discharge to hospice and in-hospital mortality. We did not, however, confirm that higher transfer-out rates were associated with lower in-hospital mortality as other studies have. 1, 3 This may CI indicates confidence interval; GWTG, Get With The Guidelines; and RSMR, risk-standardized mortality rate. *Hospitals with a lower (or higher) RSMR had a 95% confidence interval entirely below (or above) the corresponding overall average mortality rate (ie, intercept =0). In-Hospital and 30-Day Stroke Mortality be because of the fact that GWTG-Stroke hospitals transferout relative few patients-the average hospital transfer-out rate was only 2%. Overall, our data highlight the limitations of relying only on in-hospital mortality to profile hospital performance and the potential for individual hospitals to alter their practices and policies (eg, by reducing LOS and increasing hospice discharge) to gain advantage.
There are a few potential limitations and caveats to consider in this analysis. First, GWTG-Stroke hospitals are more likely to be larger stroke centers interested in stroke quality improvement, which could influence the generalizability of the findings. However, prior studies have confirmed that older patients treated at GWTG-Stroke hospitals are similar to other elderly stroke patients treated elsewhere. 17 Second, our analyses were confined to fee-for-service Medicare patients, and so it remains unclear whether the results comparing risk-standardized in-hospital and 30-day mortality data to profile hospitals would be similar if they were based on all ischemic stroke patients rather than elderly Medicare patients. Third, we used risk adjustment models that were specifically developed for GWTG-Stroke hospitals to assess in-hospital mortality, 15 but quality assessment and pay-for-performance programs use different, claims-based risk-adjustment models that contain many more covariates. 10, 11, 18 However, when applied to our data, the GWTG-Stroke risk models performed well showing good discrimination and calibration. We think it unlikely then that the results would be meaningfully different if a more complex, claims-based risk-adjustment model developed for ischemic stroke patients were available.
14 Fourth, the high mortality rate among ischemic stroke patients discharged to hospice may not be observed in other medical conditions, thus, the combined outcome may not serve as a satisfactory proxy for 30-day mortality for other diagnoses. Finally, it is possible that changes in the utilization patterns of hospice care post discharge could change the relationship between hospice use and early mortality. As our data illustrate, the rate of discharge to hospice more than doubled during the 10-year period of this study, and previous studies have highlighted the fact that the organization, structure, utilization, and outcomes of hospice services in the United States have changed dramatically over recent years. [19] [20] [21] We also note that in the future, large-scale increases in the utilization of endovascular therapies for acute stroke patients could change the relative balance between in-hospital and early postdischarge mortality, as well as the utilization and outcomes of patients discharged to hospice care.
In summary, using data from US hospitals participating in a large stroke quality improvement program, we determined that risk-standardized in-hospital mortality was not a satisfactory proxy for risk-standardized 30-day mortality data when used for identifying outlier hospitals. However, we found that the composite outcome of in-hospital mortality and discharge to hospice could serve as an adequate proxy for 30-day mortality data. Although future studies are needed to replicate these observations and to monitor the survival patterns of CI indicates confidence interval; GWTG, Get With The Guidelines; and RSMR, risk-standardized mortality rate. *Hospitals with a lower (or higher) RSMR had a 95% confidence interval entirely below (or above) the corresponding overall average mortality rate (ie, intercept =0). In-Hospital and 30-Day Stroke Mortality ischemic stroke patients who are discharged to hospice after hospitalization, our findings suggest that hospitals could use the composite outcome of in-hospital mortality and discharge to hospice in lieu of 30-day mortality data.
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